The Federal Trade Commission unanimously launched a formal inquiry into the business practices of the prescription drug middleman industry—known as pharmacy benefit managers (PBMs)—in early June 2022 due to the overwhelming response of more than 24,000 public comments during their request for information.
Listen to ACCC's Matt Devino and Dr. Rahul Seth discuss why every voice is critical in grassroots advocacy efforts on both the federal and state level, and how cancer professionals who moonlight as patient advocates can help improve access to care and reduce financial toxicity for people living with cancer.
Speakers
Matt Devino, MPH Director, Cancer Care Delivery & Health Policy Association of Community Cancer Centers
Rahul Seth, DO Assistant Professor of Medicine State University of New York Upstate Medical University
Related Resources
- State by State: Advocacy Advances PBM Reform, Part 1
- State by State: Advocacy Advances PBM Reform, Part 2
- FTC Requests Public Comments on the Impact of Pharmacy Benefit Managers’ Practices
- FTC Launches Inquiry Into Prescription Drug Middlemen Industry
- Oncology State Societies Advocacy Engagement Pilot
- ACCC Legislative Action Center